The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Cystic Fibrosis Transmembrane Regulator (CFTR) Biomarker Study to Evaluate the Rescue of Mutant CFTR in Patients With Cystic Fibrosis Treated With CFTR-modulators (Modulate-CF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04732910
Recruitment Status : Recruiting
First Posted : February 1, 2021
Last Update Posted : March 4, 2024
Sponsor:
Collaborators:
Hannover Medical School
Heidelberg University
University of Giessen
Information provided by (Responsible Party):
Simon Graeber, Charite University, Berlin, Germany

No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 31, 2027
Estimated Study Completion Date : December 31, 2027
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):